oxprenolol has been researched along with Cardiac Failure in 8 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Excerpt | Relevance | Reference |
---|---|---|
"Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate proven cardiovascular prevention in hypertension mega-trials." | 5.22 | Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. ( Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Esler, M | 1 |
Kjeldsen, SE | 1 |
Pathak, A | 1 |
Grassi, G | 1 |
Kreutz, R | 1 |
Mancia, G | 1 |
Taylor, SH | 1 |
Silke, B | 1 |
Zilcher, H | 1 |
Glogar, D | 1 |
Muiesan, G | 1 |
Valori, C | 1 |
Lopatin, IuM | 1 |
Ghani, P | 1 |
Sinitsin, VE | 1 |
Mareev, VIu | 1 |
Singh, BN | 1 |
Simpson, FO | 1 |
2 reviews available for oxprenolol and Cardiac Failure
Article | Year |
---|---|
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity | 2022 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihy | 1974 |
1 trial available for oxprenolol and Cardiac Failure
Article | Year |
---|---|
[Potential possibilities of using adrenergic beta blockers in chronic heart failure].
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Metopro | 1992 |
5 other studies available for oxprenolol and Cardiac Failure
Article | Year |
---|---|
Haemodynamic effects of beta-blockade in ischaemic heart failure.
Topics: Chronic Disease; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Oxprenolo | 1981 |
Alternatives to practolol - the argument in more detail.
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Oxprenolol; Practolol; Propranolol | 1975 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
[Sympathetic nervous activity and ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Catecholamines; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; M | 1977 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Fail | 1973 |